jp morgan glp-1 Discover J.P. Morgan's India Conference JPMorgan bets on obesity drugs

Administration Methods for Epithalon The method of administration significantly impacts bioavailability and effectiveness

As Daniel Drucker explained in the companion podcast, that isnt necessary to achieve the GLP-1 mediated suppression of inflammation in the brain

A 2025 study published in Obesity found that GLP1 users lost 7.7% of body weight on semaglutide and 12.4% on tirzepatide after one year, roughly half the weight loss seen in randomized trials

Both require consistency, and both deliver best results when combined with adequate protein intake, resistance training, and proper sleep habits

Thats not the right answer